Hishinuma Akira
Department of Clinical Laboratory Medicine, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293.
Rinsho Byori. 2005 Oct;53(10):935-41.
Congenital hypothyroidism is caused either by abnormal development of thyroid glands or by inborn errors of thyroid hormone synthesis. Thyroglobulin mutations which caused overt Cretins with physical and mental development impairment were once believed rare. However, since the discovery of mild hypothyroidism due to thyroglobulin mutations, 54 cases from 43 families were identified in Japan. The patients presented either transient elevation of serum TSH during infancy or growing giant goiters from childhood. Among 15 patients who were born after initiation of neonatal screening in 1979, 13 patients were identified by high serum TSH. In contrast, the major manifestation in patients born before 1979 is persistent growth of goiters with euthyroidism or subclinical hypothyroidism. Among 25 mutations, Cys1264Arg and Cys1077Arg are hot spots. The Cys1264Arg patients were found all over Japan, but the Cys1077Arg patients were confined to a small village of a southern island in Japan. The occurrence of the thyroglobulin mutations in the general population is 1/67,000. The pathogenesis of abnormal thyroglobulin is defective intracellular transport. The histological findings include empty colloid in the follicles and distended ER filling the entire cytoplasm of the thyrocytes. An in vitro expression study showed that abnormal thyroglobulin was not secreted from cultured cells. Because of persistent growth of the thyroid, 25 patients underwent surgical treatment. Among them, 11 patients suffered from thyroid cancers, most of which were of the papillary type. We found two BRAF activating mutations Val599Glu and Cys600Gln in five patients tested. In conclusion, we found many patients with thyroglobulin mutations in Japan. They were found by high serum TSH at neonatal screening or persistent growth of goiters in adults. Surgical treatments were inevitable, and 40% of the removed thyroids contained thyroid cancers, some of which were caused by activating mutations of the BRAF gene.
先天性甲状腺功能减退症是由甲状腺腺体发育异常或甲状腺激素合成的先天性缺陷引起的。曾认为导致明显克汀病且伴有身心发育障碍的甲状腺球蛋白突变很罕见。然而,自发现由甲状腺球蛋白突变引起的轻度甲状腺功能减退症以来,日本已从43个家庭中鉴定出54例病例。这些患者在婴儿期表现为血清促甲状腺激素(TSH)短暂升高,或从儿童期开始出现巨大甲状腺肿。在1979年新生儿筛查开始后出生的15例患者中,13例通过高血清TSH得以确诊。相比之下,1979年以前出生的患者的主要表现是甲状腺肿持续增大,伴有甲状腺功能正常或亚临床甲状腺功能减退。在25种突变中,Cys1264Arg和Cys1077Arg是热点突变。Cys1264Arg突变的患者遍布日本各地,但Cys1077Arg突变的患者局限于日本南部一个岛屿的小村庄。甲状腺球蛋白突变在普通人群中的发生率为1/67,000。异常甲状腺球蛋白的发病机制是细胞内运输缺陷。组织学检查结果包括滤泡内胶体空泡形成以及充满甲状腺细胞整个细胞质的扩张内质网。一项体外表达研究表明,异常甲状腺球蛋白不会从培养细胞中分泌出来。由于甲状腺持续增大,25例患者接受了手术治疗。其中,11例患者患有甲状腺癌,大多数为乳头状癌。在检测的5例患者中,我们发现了两种BRAF激活突变Val599Glu和Cys600Gln。总之,我们在日本发现了许多甲状腺球蛋白突变患者。他们是通过新生儿筛查时的高血清TSH或成人甲状腺肿的持续增大发现的。手术治疗不可避免,切除的甲状腺中有40%含有甲状腺癌,其中一些是由BRAF基因的激活突变引起的。